then dried by Na2SO4. The organic solvent was evaporated and
the crude product was purified by flash chromatography to
produce a purple solid.
porphyrin (31 mg, 0.05 mmol), K3PO4 (212 mg, 1 mmol),
3-formylbenzeneboronic acid neopentyl glycol cyclic ester
(109 mg, 0.5 mmol) and Pd(PPh3)4 (5.8 mg, 0.005 mmol) in
THF (20 ml) gave a purple solid (26 mg, 78%); column chroma-
tography (silica, 20% hexane in dichloromethane; Rf = 0.35);
mp >350 ЊC (decomp.); λmax(CH2Cl2)/nm (log (ε/dm3 molϪ1
cmϪ1)) 419 (5.8), 514 (4.2), 550 (3.8), 591 (3.7) and 642 (3.4);
δH (400 MHz, CDCl3) Ϫ2.78 (2H, br s, NH), 7.76–7.80 (6H,
m, 10,20-Ar-3,4,5H), 7.93–7.97 (2H, t, J = 7.6, 5,15-Ar-5H),
8.21–8.23 (4H, m, 10,20-Ar-2,6H), 8.32–8.35 (2H, m, 5,15-Ar-
6H), 8.48–8.50 (2H, m, 5,15-Ar-4H), 8.71 (2H, br s, 5,15-
Ar-2H), 8.76–8.77 (4H, d, J = 4.8, β-pyrrole H), 8.88–8.89 (4H,
d, J = 4.8, β-pyrrole H) and 10.32 (2H, s, CHO); δC (100 MHz,
CDCl3) 118.4, 120.8, 126.8, 127.6, 127.9, 128.9, 134.6, 135.0,
135.2, 139.8, 141.9, 143.2 and 192.6; HRMS (EI) calc. for
C46H30N4O2 670.2369, found 670.2358.
5,15-Bis(4-methoxyphenyl)-10,20-diphenylporphyrin
(4).
Following the general procedure 5,15-dibromo-10,20-diphenyl-
porphyrin (31 mg, 0.05 mmol), K3PO4 (212 mg, 1 mmol), 4-
methoxybenzeneboronic acid (76 mg, 0.5 mmol) and Pd(PPh3)4
(5.8 mg, 0.005 mmol) in THF (20 ml) gave a purple solid
(25 mg, 74%); column chromatography (silica, 50% hexane
in dichloromethane, Rf = 0.23); mp >350 ЊC (decomp.);
λmax(CH2Cl2)/nm (log (ε/dm3 molϪ1 cmϪ1)) 420 (5.8), 516 (4.5),
553 (4.3), 594 (4.2) and 649 (4.2); δH (400 MHz, CDCl3) Ϫ2.77
(2H, br s, NH), 4.09 (6H, s, OCH3), 7.27–7.30 (4H, m, 5,15-Ar-
3,5H), 7.76–7.78 (6H, m, 10,20-Ar-3,4,5H), 8.11–8.14 (4H, m,
5,15-Ar-2,6H), 8.21–8.23 (4H, m, 10,20-Ar-2,6H) and 8.83–
8.88 (8H, m, β-pyrrole H); δC (100 MHz, CDCl3) 55.7, 112.3,
120.0, 120.1, 126.8, 127.8, 131.0, 134.6, 135.7, 142.3 and 159.5;
HRMS (EI) calc. for C46H34N4O2 674.2682, found 674.2672.
5,15-Bis(4-methoxyphenyl)-10,20-(4-methylphenyl)porphyrin
(9). Following the general procedure 5,15-dibromo-10,20-bis-
(4-methylphenyl)porphyrin (20 mg, 0.031 mmol), K3PO4
(131 mg, 0.62 mmol), 4-methoxybenzeneboronic acid (47 mg,
0.31 mmol) and Pd(PPh3)4 (3.6 mg, 0.0031 mmol) in THF
(15 ml) gave a purple solid (16 mg, 73%); column chroma-
tography (silica, dichloromethane; Rf = 0.91); mp >350 ЊC
(decomp.); λmax(CH2Cl2)/nm (log (ε/dm3 molϪ1 cmϪ1)) 421 (5.7),
517 (4.2), 554 (4.0), 592 (3.7) and 649 (3.7); δH (400 MHz,
CDCl3) Ϫ2.77 (2H, br s, NH), 2.71 (6H, s, CH3), 4.10 (6H, s,
OCH3), 7.28–7.30 (4H, m, 5,15-Ar-3,5H), 7.55–7.57 (4H, m,
10,20-Ar-3,5H), 8.09–8.14 (8H, m, 5,10,15,20-Ar-2,6H) and
8.86 (8H, s, β-pyrrole H); δC (67.8 MHz, CDCl3) 21.6, 53.5,
112.2, 127.4, 127.6, 130.9, 134.6, 135.6, 137.4, 139.3 and 164.0;
HRMS (EI) calc. for C48H38N4O2 702.2995, found 702.2993.
5,15-Bis(4-methylphenyl)-10,20-diphenylporphyrin
(5).
Following the general procedure 5,15-dibromo-10,20-diphenyl-
porphyrin (31 mg, 0.05 mmol), K3PO4 (212 mg, 1 mmol), 4-
methylbenzeneboronic acid (68 mg, 0.5 mmol) and Pd(PPh3)4
(5.8 mg, 0.005 mmol) in THF (20 ml) gave a purple solid
(23 mg, 74%); column chromatography (silica, 30% hexane
in dichloromethane; Rf = 0.88); mp >350 ЊC (decomp.);
λmax(CH2Cl2)/nm (log (ε/dm3 molϪ1 cmϪ1)) 418 (5.7), 515 (4.2),
550 (3.9), 590 (3.7) and 647 (3.5); δH (400 MHz, CDCl3) Ϫ2.77
(2H, br s, NH), 2.69 (6H, s, CH3), 7.53–7.55 (4H, d, J = 7.8,
5,15-Ar-3,5H), 7.71–7.78 (6H, m, 10,20-Ar-3,4,5H), 8.08–8.10
(4H, m, 10,20-Ar-2,6H), 8.18–8.23 (4H, m, 5,15-Ar-2,6H)
and 8.82–8.87 (8H, m, β-pyrrole H); δC (67.8 MHz, CDCl3)
21.6, 120.0, 120.3, 126.7, 126.8, 127.5, 127.7, 131.1, 134.6,
134.7, 137.4, 139.3 and 142.3; HRMS (EI) calc. for C46H34N4
642.2783, found 642.2784.
5,15-Bis(4-methoxyphenyl)-10,20-bis(4-methoxycarbonyl-
phenyl)porphyrin (10). Following the general procedure 5,15-di-
bromo-10,20-bis(4-methoxycarbonylphenyl)porphyrin (28 mg,
0.038 mmol), K3PO4 (161 mg, 0.76 mmol), 4-methoxybenzene-
boronic acid (58 mg, 0.38 mmol) and Pd(PPh3)4 (4.4 mg, 0.0038
mmol) in THF (15 ml) gave a purple solid (23 mg, 77%);
column chromatography (silica, dichloromethane; Rf = 0.17);
mp >350 ЊC (decomp.); λmax(CH2Cl2)/nm (log (ε/dm3 molϪ1
cmϪ1)) 420 (5.8), 517 (4.5), 553 (4.2), 592 (4.0) and 649 (3.9); δH
(400 MHz, CDCl3) Ϫ2.79 (2H, br s, NH), 2.50 (6H, s,
C(O)OCH3), 4.10 (6H, s, OCH3), 7.29–7.31 (4H, m, 5,15-Ar-
3,5H), 7.49–7.51 (4H, m, 10,20-Ar-3,5H), 8.11–8.13 (4H, m,
5,15-Ar-2,6H), 8.21–8.23 (4H, m, 10,20-Ar-2,6H) and 8.85–
8.89 (8H, m, β-pyrrole H); δC (100 MHz, CDCl3) 21.4, 55.6,
112.3, 118.9, 119.9, 120.1, 131.1, 134.5, 135.4, 135.6, 139.8,
150.6, 159.5 and 169.6; HRMS (EI) calc. for C50H38N4O6
790.2791, found 790.2789.
5,10,15,20-Tetraphenylporphyrin (6). Following the general
procedure 5,15-dibromo-10,20-diphenylporphyrin (31 mg,
0.05 mmol), K3PO4 (212 mg, 1 mmol), benzeneboronic acid
(61 mg, 0.5 mmol) and Pd(PPh3)4 (5.8 mg, 0.005 mmol) in THF
(20 ml) gave a purple solid (23 mg, 75%); column chroma-
tography (silica, 40% hexane in dichloromethane; Rf = 0.75);
mp >350 ЊC (decomp.); λmax(CH2Cl2)/nm (log (ε/dm3 molϪ1
cmϪ1)) 417 (5.7), 514 (4.3), 549 (4.0), 589 (3.7) and 645(3.6);
δH (400 MHz, CDCl3) Ϫ2.77 (2H, br s, NH), 7.74–7.77 (12H,
m, 5,10,15,20-Ar-3,4,5H), 8.20–8.23 (8H, m, 5,10,15,20-Ar-
2,6H) and 8.85 (8H, m, β-pyrrole H); δC (100 MHz, CDCl3)
120.2, 126.8, 127.8, 131.4, 134.7 and 142.3; HRMS (EI) calc.
for C44H30N4 614.2470, found 614.2470.
5,15-Bis(4-acetylphenyl)-10,20-diphenylporphyrin (7). Follow-
ing the general procedure 5,15-dibromo-10,20-diphenylpor-
phyrin (31 mg, 0.05 mmol), K3PO4 (212 mg, 1 mmol), 4-acetyl-
benzeneboronic acid neopentyl glycol cyclic ester (116 mg,
0.5 mmol) and Pd(PPh3)4 (5.8 mg, 0.005 mmol) in THF (20 ml)
gave a purple solid (27 mg, 77%); column chromatography
(silica, dichloromethane; Rf = 0.36); mp >350 ЊC (decomp.);
λmax(CH2Cl2)/nm (log (ε/dm3 molϪ1 cmϪ1)) 419 (5.5), 515 (4.1),
551 (3.8), 590 (3.6) and 645 (3.5); δH (400 MHz, CDCl3) Ϫ2.79
(2H, br s, NH), 2.89 (6H, s, C(O)CH3), 7.73–7.80 (6H, m, 10,20-
Ar-3,4,5H), 8.20–8.22 (4H, m, 5,15-Ar-3,5H), 8.31–8.38 (8H,
m, 5,10,15,20-Ar-2,6H), 8.79–8.80 (4H, d, J = 4.8, β-pyrrole H)
and 8.87–8.88 (4H, d, J = 4.8, β-pyrrole H); δC (100 MHz,
CDCl3) 27.0, 118.9, 120.7, 126.7, 126.8, 127.9, 131.7, 134.6,
134.8, 136.4, 141.9, 147.2 and 198.3; HRMS (EI) calc. for
C48H34N4O2 698.2682, found 698.2680.
5,15-Bis(4-methoxyphenyl)-10-(4-nitrophenyl)-20-(4-methoxy-
carbonylphenyl)porphyrin (11). Following the general procedure
5,15-dibromo-10-(4-nitrophenyl)-20-(4-methoxycarbonylphenyl)-
porphyrin (24 mg, 0.033 mmol), K3PO4 (141 mg, 0.66 mmol),
4-methoxybenzeneboronic acid (50 mg, 0.33 mmol) and Pd-
(PPh3)4 (3.8 mg, 0.0033 mmol) in THF (15 ml) gave a purple
solid (20 mg, 78%); column chromatography (silica, dichloro-
methane; Rf = 0.54); mp >350 ЊC (decomp.); λmax(CH2Cl2)/nm
(log (ε/dm3 molϪ1 cmϪ1)) 422 (5.6), 518 (4.3), 552 (4.0), 592 (3.7)
and 649 (3.6); δH (400 MHz, CDCl3) Ϫ2.78 (2H, br s, NH), 2.50
(3H, s, C(O)OCH3), 4.10 (6H, s, OCH3), 7.27–7.31 (4H, m,
5,15-Ar-3,5H), 7.48–7.52 (2H, m, 20-Ar-3,5H), 8.09–8.13 (4H,
m, 5,15-Ar-2,6H), 8.20–8.23 (2H, m, 10-Ar-3,5H), 8.37–8.40
(2H, m, 20-Ar-2,6H), 8.61–8.64 (2H, m, 10-Ar-2,6H), 8.72–8.73
(2H, br d, J = 5.8, β-pyrrole H) and 8.87–8.92 (6H, m, β-pyrrole
H); δC (100 MHz, CDCl3) 55.6, 112.4, 116.7, 120.0, 120.6,
121.9, 131.2, 131.9, 134.2, 135.2, 135.4, 135.6, 139.6, 147.7,
149.3, 150.7, 159.6 and 169.6; HRMS (EI) calc. for C48H35N5O6
777.2587, found 777.2578.
5,15-Bis(3-formylphenyl)-10,20-diphenylporphyrin
(8).
Following the general procedure 5,15-dibromo-10,20-diphenyl-
J. Chem. Soc., Perkin Trans. 1, 2002, 1397–1400
1399